Literature DB >> 21420715

Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.

Wen-Chuang Wang1, Tsung-Teh Wu, Vishal S Chandan, Christine M Lohse, Lizhi Zhang.   

Abstract

Esophageal squamous intraepithelial neoplasia has been widely recognized as a precursor lesion for esophageal squamous cell carcinoma. Early detection offers the best prognosis for esophageal squamous cell carcinoma. The differentiation of squamous dysplasia from reactive change and the classification of squamous dysplasia into high-grade or low-grade are sometimes subjective and challenging. In this study, we sought to evaluate multiple biomarkers and to develop clinically useful adjunct tools for difficult esophageal squamous intraepithelial neoplasia cases. Immunohistochemical stains using antibodies against Ki-67, ProExC, p16, and p53 were performed on esophageal biopsy or resection specimens from 25 patients including 35 foci of high-grade dysplasia and 25 foci of low-grade dysplasia, and from 10 control cases containing 52 foci of normal/reactive hyperplasia. In situ hybridization tests for human papillomavirus were performed in 11 cases. The immunostains for all 4 markers were scored as negative, intermediate, and strong according to established criteria. Intermediate and strong Ki-67 and ProExC staining showed similar detecting power and exhibited very high sensitivity and specificity for distinguishing normal/reactive hyperplasia from esophageal squamous intraepithelial neoplasia and normal/reactive hyperplasia from low-grade esophageal squamous intraepithelial neoplasia. Strong Ki-67 staining was exclusively seen in high-grade esophageal squamous intraepithelial neoplasia, which provided additional value in distinguishing high-grade from low-grade esophageal squamous intraepithelial neoplasia. Strong ProExC staining was also seen in most high-grade esophageal squamous intraepithelial neoplasia foci (80%). Although the frequencies of intermediate/strong staining patterns of p53 increased with increasing degree of dysplasia, the sensitivity of p53 was much lower than that of Ki-67 and ProExC. p16 did not show consistent immunostain pattern in the normal/reactive hyperplasia and esophageal squamous intraepithelial neoplasia. Two (18%) of 11 tested cases were positive for human papillomavirus infection. This study demonstrates that both Ki-67 and ProExC can be used as an adjunct tool for diagnosing difficult cases of esophageal squamous intraepithelial neoplasia.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420715     DOI: 10.1016/j.humpath.2010.12.009

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Diagnostic implications of Ki-67 expression in adipocytes and lipoblasts: an immunohistochemical study.

Authors:  Hong-Jun Wang; Cong-Yang Li; Yang-Kun Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

2.  p16 overexpression in malignant and premalignant lesions of the oral and esophageal mucosa following allogeneic hematopoietic stem cell transplantation.

Authors:  Yasumasa Kakei; Masaya Akashi; Hideki Komatsubara; Tsutomu Minamikawa; Takahide Komori
Journal:  Head Neck Oncol       Date:  2012-06-23

3.  Differentiation-associated genes regulated by c-Jun and decreased in the progression of esophageal squamous cell carcinoma.

Authors:  Aiping Luo; Xinfeng Yu; Guichang Li; Gang Ma; Hongyan Chen; Fang Ding; Yi Li; Zhihua Liu
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

4.  Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program.

Authors:  Hao Zhang; Hao Li; Qing Ma; Fang-Yan Yang; Tao-Yu Diao
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

5.  Immunocytoexpression profile of ProExC in smears interpreted as ASC-US, ASC-H, and cervical intraepithelial lesion.

Authors:  Zeynep Tosuner; İlknur Türkmen; Sema Arici; Cavide Sönmez; Seval Turna; Öykü Onaran
Journal:  J Cytol       Date:  2017 Jan-Mar       Impact factor: 1.000

6.  Epigenetic Reprogramming of Lineage-Committed Human Mammary Epithelial Cells Requires DNMT3A and Loss of DOT1L.

Authors:  Jerrica L Breindel; Adam Skibinski; Maja Sedic; Ania Wronski-Campos; Wenhui Zhou; Patricia J Keller; Joslyn Mills; James Bradner; Tamer Onder; Charlotte Kuperwasser
Journal:  Stem Cell Reports       Date:  2017-08-03       Impact factor: 7.765

7.  The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma.

Authors:  George Couch; James E Redman; Lorenz Wernisch; Richard Newton; Shalini Malhotra; Sanford M Dawsey; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  Cancer Prev Res (Phila)       Date:  2016-04-12

8.  Comparison of long non‑coding RNAs, microRNAs and messenger RNAs involved in initiation and progression of esophageal squamous cell carcinoma.

Authors:  Su-Qing Li; Feng Li; Yun Xiao; Chun-Mei Wang; Lei Tuo; Jing Hu; Xiao-Bin Yang; Jin-Song Wang; Wei-Hong Shi; Xia Li; Xiu-Feng Cao
Journal:  Mol Med Rep       Date:  2014-05-30       Impact factor: 2.952

9.  Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.

Authors:  Amol R Gadbail; Minal Chaudhary; Sachin C Sarode; Shailesh Gondivkar; Satyajit A Tekade; Prajakta Zade; Alka Hande; Gargi S Sarode; Shankargouda Patil
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.